-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
SpringWorks Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2017 to Q2 2024.
- SpringWorks Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $6.78M, a 16.3% increase year-over-year.
- SpringWorks Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $25.9M, a 50.8% increase year-over-year.
- SpringWorks Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $22.9M, a 273% increase from 2022.
- SpringWorks Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $6.15M, a 1026% increase from 2021.
- SpringWorks Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $546K, a 59.7% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)